OFIX Profile
Orthofix Medical Inc., headquartered in Lewisville, Texas, operates as a prominent player in the medical device and biologics industry, with operations spanning across the United States, Europe, Brazil, and other global markets. The company is structured into two distinct segments: Global Spine and Global Orthopedics.
The Global Spine segment focuses on manufacturing and distributing bone growth stimulator devices that facilitate bone fusion and serve as therapeutic treatments for non-spinal and appendicular fractures. Additionally, this segment designs, develops, and markets a wide-ranging portfolio of motion preservation and fixation implants used in spine surgeries. Orthofix also offers various products and tissue forms enabling physicians to address a spectrum of spinal and orthopedic conditions, along with regenerative solutions derived from synthetic materials.
In the Global Orthopedics segment, Orthofix specializes in the design, development, and marketing of orthopedic products crucial for fracture repair, deformity correction, and bone reconstruction procedures. These products cater to a broad customer base including physicians, hospitals, ambulatory surgery centers, and integrated health delivery systems, underscoring Orthofix's commitment to providing advanced orthopedic solutions.
Utilizing a robust distribution network that includes direct sales representatives, independent distributors, and employed and independent sales representatives, Orthofix effectively reaches its target markets. Established in 1980 and formerly known as Orthofix International N.V., the company rebranded to Orthofix Medical Inc. in July 2018, signaling its evolution and commitment to advancing medical innovation and enhancing patient outcomes worldwide.
|
